Citric Acid for Health & Longevity - Quick Reference Sheet

Citric Acid for Health & Longevity

Created on 07/09/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Citric acid's charged form, citrate, is most useful as mineral salts—especially potassium citrate—which strongly cut the return of calcium kidney stones and help dissolve uric acid stones. Salts also aid calcium and magnesium absorption and give a small exercise edge. Plain citric acid does far less, and can erode tooth enamel; longevity claims remain animal-only. (Full Review)

Protocol

Stone Prevention
Potassium citrate
30–60 mEq/day in 2–3 divided doses, titrated to urine pH 6.0–6.5
Exercise Buffering
Sodium citrate
0.3–0.5 g/kg, split, 120–180 min before intense exercise
Mineral Absorption
Calcium/magnesium citrate
Divided doses; absorbed largely independent of stomach acid
Time to effect
Stone Prevention
Months–years
Fewer stones; urine chemistry shifts within 1–2 days
Uric Acid Stones
Weeks–months
Raising urine pH dissolves existing stones
Exercise Buffering
Within hours
Acute effect from a single pre-exercise dose

Benefits

Contraindications
  • Aluminum-containing antacids or sucralfate (in kidney impairment)
  • Chronic kidney disease (advanced)
  • Untreated hyperkalemia
  • Severe urinary tract infection with urea-splitting organisms
  • Strict sodium restriction (with sodium citrate)
Key Interactions
  • Potassium-sparing diuretics, ACE inhibitors, ARBs, potassium supplements (spironolactone, lisinopril, losartan)
  • Drugs cleared via urine pH (quinidine, amphetamines, salicylates, lithium)
  • NSAIDs
  • Effervescent or antacid products containing citrate
  • Salt substitutes and other potassium-raising supplements

Risk & Side Effects

  • High: Dental enamel erosion; gastrointestinal irritation
  • Medium: Hyperkalemia with potassium citrate; enhanced aluminum absorption; metabolic alkalosis and over-alkalinized urine
  • Low: Allergic and inflammatory reactions to manufactured citric acid; skin and respiratory irritation
  • Speculative: Systemic inflammation from chronic additive exposure

Monitoring

Marker Target Why
24-hour urinary citrate >640 mg/day Confirms citrate therapy is achieving its main goal
Urine pH 6.0–6.5 (calcium); 6.5–7.0 (uric acid) Guides alkali dosing and prevents over-alkalinization
Serum potassium 4.0–4.5 mmol/L Detects hyperkalemia from potassium citrate
Serum bicarbonate (CO2) 22–28 mmol/L Detects excess alkali load (metabolic alkalosis)
24-hour urinary calcium <200 mg/day Tracks the calcium-lowering effect relevant to stones and bone
eGFR / serum creatinine eGFR >90 mL/min/1.73 m² Confirms kidney function is adequate for safe citrate salt use
Serum magnesium 2.0–2.5 mg/dL Relevant when using magnesium citrate or with diarrhea

Cadence: Baseline before starting; recheck 6–12 weeks after starting or changing dose, then every 6–12 months once stable

Qualitative Assessment

  • Absence of new stone episodes or renal colic over time
  • Good gastrointestinal tolerance without persistent loose stools or cramping
  • No new or worsening tooth sensitivity or visible enamel wear
  • Stable energy and no symptoms of electrolyte disturbance such as muscle weakness or palpitations